<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd">
<head>
<meta http-equiv="default-style" content="text/html; charset=utf-8" />
<title>Campbell-Walsh-Wein Urology Twelfth Edition Review</title>
<link rel="stylesheet" type="text/css" href="../../style/Elsevier_eBook.css" />
<link rel="stylesheet" type="text/css" media="only screen" href="../../style/media.css" />
  

<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/common.css" />
<link rel="stylesheet" type="text/css" href="../../widgets/common_assets/css/variables.css" />
<script type="text/javascript" src="../../widgets/common_assets/scripts/mathjax/tex-mml-chtml.js"></script>
<script type="text/javascript" src="../../widgets/common_assets/scripts/common.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_data.js"></script>
<script type="text/javascript" src="../../widgets/img_lightbox_handler/img_lightbox_parent.js"></script>

</head>
<body>
<section epub:type="chapter">
<a id="c0087"></a>
<header>
<div id="CN">87</div>
<h1 class="chaptitle" epub:type="title" id="B9780323639699000872">Renal Insufficiency and Ischemic Nephropathy</h1>
<address>
<div class="chapau" id="augrp0010">Joshua J. Augustine, Alvin C. Wee, Venkatesh Krishnamurthi, and David A. Goldfarb</div>
</address>
</header>
<section>
<h3 class="h2hd" id="cesectitle0010">Keywords</h3>
<div class="keywords">acute kidney injury; ischemic nephropathy; renal artery disease; renal failure</div>
</section>
<section>
<section>
<a id="s0010"></a>
<h2 class="h1hd" id="cesectitle0015">Questions</h2>
<div id="p0010"></div>
<div>
    <div>

<iframe src="../../widgets/MCMS/xhtml/ch087_assessments.xhtml" height="630"></iframe>
<div class="pageavoid">
<figure class="fig" id="f0010">
<img src="../../IMAGES/B9780323639699000872/main.assets/f87-01-9780323639699.jpg" alt="image"/>
<figcaption class='figleg'>
<span class="fignum">Fig. 87.1</span>
</figcaption>
</figure>
</div>
</div>


<div>

<div class="boxg1" id="b0010">
<p></p>
<div class="b1title" epub:type="title" id="title5050">Chapter Review</div>
<div id="bpar0010"></div>
<div>
<ul class="ce_list" id="olist0160">
<li class="b1numlist" id="bpar0015">
<a id="o0920"></a>1. ARF is divided into prerenal, intrarenal, and postrenal.</li>
<li class="b1numlist" id="bpar0020">
<a id="o0925"></a>2. Prerenal failure is the result of decreased renal blood flow or increased nitrogen load. The serum blood urea nitrogen-to-creatinine ratio is greater than 10:1. Urine volume is generally low, osmolality high, and sodium content very low.</li>
<li class="b1numlist" id="bpar0025">
<a id="o0930"></a>3. Intrarenal failure is due to parenchymal disease. It may involve the glomerulus as in acute glomerulonephritis, the tubule as in ATN, or the interstitium as in acute interstitial nephritis. The serum blood urea nitrogen-to-creatinine ratio is 10:1. Urine output is variable, and urinary sodium is generally above 20 mEq/L. If the cause is ATN, urinary sodium is generally greater than 40 mEq/L.</li>
<li class="b1numlist" id="bpar0030">
<a id="o0935"></a>4. Postrenal failure is due to obstruction of the entire nephron mass. Patients who are anuric should be suspected of having complete urinary tract obstruction, acute cortical necrosis, or bilateral vascular occlusion. The serum blood urea nitrogen-to-creatinine ratio is 10:1.</li>
<li class="b1numlist" id="bpar0035">
<a id="o0940"></a>5. In ATN, renal blood flow is reduced by 50% or more with the perfusion defect most marked in the outer medulla. Tubule permeability is also increased.</li>
<li class="b1numlist" id="bpar0040">
<a id="o0945"></a>6. The use of mannitol before an ischemic insult has been shown to be of benefit.</li>
<li class="b1numlist" id="bpar0045">
<a id="o0950"></a>7. Hyperkalemia, as evidenced on the electrocardiogram by peaked T-waves, a prolonged PR interval, and widening of the QRS complex is initially treated with IV calcium salts to stabilize the myocardium and then transiently lower serum potassium with IV glucose and insulin or IV sodium bicarbonate, as well as to permanently lower the potassium with either Kayexalate or dialysis. Administration of Kayexalate has been associated with colonic necrosis</li>
<li class="b1numlist" id="bpar0050">
<a id="o0955"></a>8. The indications for initiation of dialysis include volume overload, severe hyperkalemia, severe metabolic acidosis, pericarditis, selected poisonings, and uremic symptomatology.</li>
<li class="b1numlist" id="bpar0055">
<a id="o0960"></a>9. Peritoneal dialysis is less stressful hemodynamically.</li>
<li class="b1numlista" id="bpar0060">
<a id="o0965"></a>10. The mortality rate for patients with ATN approximates 50%. Of those who survive ATN, 5% will require chronic dialysis.</li>
<li class="b1numlista" id="bpar0065">
<a id="o0970"></a>11. Patients who are to receive IV contrast and are at risk for renal failure should be given IV hydration with saline before the use of nonionic IV contrast.</li>
<li class="b1numlista" id="bpar0070">
<a id="o0975"></a>12. CKD is defined as a GFR less than 60 mL/min.</li>
<li class="b1numlista" id="bpar0075">
<a id="o0980"></a>13. Hyperfiltration results when a decreased number of nephrons are called on to perform the entire workload. This results in elevated glomerular hydrostatic pressure, which is a major contributor to decreased renal function.</li>
<li class="b1numlista" id="bpar0080">
<a id="o0985"></a>14. A family history of ESRD is a strong predictor of future risk for renal failure.</li>
<li class="b1numlista" id="bpar0085">
<a id="o0990"></a>15. The Cockcroft Gault formula, MDRD equation, and CKD-EPI equation are all used to estimate GFR from serum creatinine. These equations are inaccurate for patients who have changing renal function, are at the extremes of age or body size, are obese, have decreased muscle mass, or are sick with moderately advanced renal failure.</li>
<li class="b1numlista" id="bpar0090">
<a id="o0995"></a>16. Cystatin-C, a serum protein, may be more predictive of renal function than creatinine.</li>
<li class="b1numlista" id="bpar0095">
<a id="o1000"></a>17. Mortality rates secondary to sepsis are one to several hundred times higher in dialysis patients.</li>
<li class="b1numlista" id="bpar0100">
<a id="o1005"></a>18. Creatinine is secreted by the renal tubule and may overestimate renal function, particularly at low GFRs. Cimetidine and trimethoprim block this secretion.</li>
<li class="b1numlista" id="bpar0105">
<a id="o1010"></a>19. Drugs that block angiotensin II production or action appear to decrease the rate of decline in renal function in patients with chronic renal disease.</li>
<li class="b1numlista" id="bpar0110">
<a id="o1015"></a>20. In urology, rhabdomyolysis is associated with the protracted exaggerated lithotomy and lateral decubitus positions.</li>
<li class="b1numlista" id="bpar0115">
<a id="o1020"></a>21. The sentinel event in renal ischemia is depletion of ATP.</li>
<li class="b1numlista" id="bpar0120">
<a id="o1025"></a>22. The presence of albumen in the urine of patients with chronic renal failure is an important predictor of the rate of decline in renal function.</li>
<li class="b1numlista" id="bpar0125">
<a id="o1030"></a>23. When the GFR falls below 50% of normal, progressive loss of renal function occurs even though the cause of the renal failure is inactive or no longer present.</li>
<li class="b1numlista" id="bpar0130">
<a id="o1035"></a>24. The remaining lifetime for patients on dialysis is 15% to 25% of the general population.</li>
<li class="b1numlista" id="bpar0135">
<a id="o1040"></a>25. Myoglobin can be nephrotoxic to the proximal tubule and may result in ATN. Early recognition of muscle necrosis with resultant myoglobinuria is crucial because a forced alkaline diuresis is indicated to minimize nephrotoxicity.</li>
<li class="b1numlista" id="bpar0140">
<a id="o1045"></a>26. A low fractional excretion of sodium (or renal failure index) may be associated with either prerenal azotemia or acute glomerulonephritis.</li>
<li class="b1numlista" id="bpar0145">
<a id="o1050"></a>27. Gadolinium-based contrast agents have been associated with the development of nephrogenic systemic fibrosis. Patients at risk are those with advanced CKD.</li>
<li class="b1numlista" id="bpar0150">
<a id="o1055"></a>28. Individuals with bilateral renal artery stenosis and those with autosomal dominant PKD with cyst size greater than 10 cm may experience a decrease in residual renal function when receiving ACE inhibitor therapy.</li>
</ul>
</div>
</div>
</div>
</div>
</section>
</section><span id="s0015"></span><span id="s0020"></span><span id="f0010"></span><span id="pagebreak_335"></span><span id="pagebreak_336"></span><span id="pagebreak_337"></span>
</section>
</body>
</html>
